Revenue
$184.4M
▲ 404.5% YoY
Net Income
-$6.9M
▲ 92.3% YoY
EPS
$-0.12
▲ 92.7% YoY
Cash
$84.2M
▼ 34.2% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Hoitt Jason Chief Patient Officer | Vest | Mar 15, 2026 | 10.0K | $0.00 | $0 | Form 4 ↗ |
Leggett Thomas Chief Financial Officer | Vest | Mar 15, 2026 | 14.8K | $0.00 | $0 | Form 4 ↗ |
Ticho Barry CHIEF MEDICAL OFFICER | Vest | Mar 15, 2026 | 13.1K | $0.00 | $0 | Form 4 ↗ |
Ticho Barry CHIEF MEDICAL OFFICER | Vest | Mar 15, 2026 | 10.0K | $0.00 | $0 | Form 4 ↗ |
Ticho Barry CHIEF MEDICAL OFFICER | Vest | Mar 15, 2026 | 10.8K | $0.00 | $0 | Form 4 ↗ |
Kaye Edward M. MD | Vest | Mar 15, 2026 | 35.5K | $0.00 | $0 | Form 4 ↗ |
Kaye Edward M. MD | Vest | Mar 15, 2026 | 26.3K | $0.00 | $0 | Form 4 ↗ |
Allan Jonathan GENERAL COUNSEL & CORP SEC | Vest | Mar 15, 2026 | 7.5K | $0.00 | $0 | Form 4 ↗ |
Allan Jonathan GENERAL COUNSEL & CORP SEC | Vest | Mar 15, 2026 | 6.0K | $0.00 | $0 | Form 4 ↗ |
Allan Jonathan GENERAL COUNSEL & CORP SEC | Vest | Mar 15, 2026 | 12.0K | $0.00 | $0 | Form 4 ↗ |
LEVIN ARTHUR A | Sell | Mar 13, 2026 | 605 | $36.80 | $22K | Form 4 ↗ |
TZIANABOS ARTHUR Interim Executive Chair | Vest | Mar 10, 2026 | 4.0K | $8.33 | $33K | Form 4 ↗ |
TZIANABOS ARTHUR Interim Executive Chair | Sell | Mar 10, 2026 | 4.4K | $40.00 | $174K | Form 4 ↗ |
Krainer Adrian R. | Sell | Mar 10, 2026 | 33.2K | $39.74 | $1.32M | Form 4 ↗ |
Krainer Adrian R. | Sell | Mar 2, 2026 | 7.2K | $39.66 | $287K | Form 4 ↗ |